Provided by Tiger Trade Technology Pte. Ltd.

First Advantage Corp.

20.90
-0.3300-1.55%
Post-market: 20.900.00000.00%16:10 EDT
Volume:1.56M
Turnover:32.77M
Market Cap:3.59B
PE:143.92
High:21.36
Open:21.28
Low:20.74
Close:21.23
52wk High:25.15
52wk Low:8.82
Shares:171.54M
Float Shares:93.74M
Volume Ratio:0.76
T/O Rate:1.67%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.1452
EPS(LYR):-0.2011
ROE:1.94%
ROA:2.82%
PB:2.77
PE(LYR):-103.95

Loading ...

S&P Dow Jones Indices Says First Advantage Corporation Will Replace Kennedy-Wilson Holdings Inc. in the S&P Smallcap 600

THOMSON REUTERS
·
Jun 12

First Advantage director Clark James Lindsey reports sale of 4,921 common shares for $77,195.49

Reuters
·
Jun 11

First Advantage Shareholders Endorse Board, Pay and Auditor

TIPRANKS
·
Jun 09

First Advantage holds annual shareholder meeting

Reuters
·
Jun 09

First Advantage Chief Legal Officer Bret T. Jardine disposes of 25,000 common shares for $417,640

Reuters
·
Jun 04

Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Jun 02

Solid Biosciences to Participate at Upcoming Investor Conferences

GlobeNewswire
·
Jun 01

First Advantage publishes investor presentation outlining AI-driven screening, digital identity strategy

Reuters
·
May 30

Assessing First Advantage (FA) Valuation After A Strong Short Term Share Price Rebound

Simply Wall St.
·
May 30

X-FAB Shares Surge 77% Following AI Chip Analyst's Bullish Endorsement, Sparking Retail Investor Frenzy

Deep News
·
May 28

Lexeo Therapeutics to Participate in the 2026 RBC Capital Markets Global Healthcare Conference

GlobeNewswire
·
May 19

Design Therapeutics announces biomarker, clinical data from RESTORE-FA trial

TIPRANKS
·
May 18

Exploring US High Growth Tech Stocks This May 2026

Simply Wall St.
·
May 15

Myles Minter Reiterates Buy on Larimar as Nomlabofusp Advances Toward 2026 BLA and Potential First Disease‑Modifying FA Therapy by 2027

TIPRANKS
·
May 15

First Advantage Chief Legal Officer Bret T. Jardine disposes shares worth $15,749.88

Reuters
·
May 14

Press Release: Solid Biosciences Reports First Quarter 2026 Financial Results and Provides Business Updates

Dow Jones
·
May 13

First Advantage Is Maintained at Neutral by Citigroup

Dow Jones
·
May 11

First Advantage price target raised to $18 from $15 at Citi

TIPRANKS
·
May 11

Press Release: Lexeo Therapeutics Reports First Quarter 2026 Financial Results and Operational Highlights

Dow Jones
·
May 11

First Advantage President Joelle M. Smith disposes of $350,012 common shares

Reuters
·
May 09